The UK's health regulator says it has approved Ronapreve, the antibody developed by Roche and Regeneron to prevent and treat Covid-19, Reuters reports.
The Medicines and Healthcare products Regulatory Agency said the approval was the first in the UK for a monoclonal antibody treatment for the disease caused by the coronavirus.